Carolinas Healthcare System

Charlotte, North Carolina 28262

0 studies enrolling now · 50 studies all time

What they study most

Acid Reflux, Acquired Brain Injury (Including Stroke), Aneurysm of Ascending Aorta, Aortic Valve Disorder, Aortic Valve Stenosis, Atrial Fibrillation, Bicuspid Valve Disorder, Bladder Cancer, Breast Cancer, Breast Neoplasms, Cancer, Hepatocellular, Carcinoma

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors — Running, not enrolling
• An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux — Stopped early
• Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). — Running, not enrolling
• A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer — Running, not enrolling
• Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis — Completed
• Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration — Stopped early
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma — Completed
• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes — Completed
• Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects — Completed
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) — Stopped early
• Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD) — NO_LONGER_AVAILABLE
• An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) — Completed
• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) — Completed
• Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery — Completed
• Pulmonary Embolism Short-term Clinical Outcomes Registry — Completed
• LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer — Stopped early
• Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) — Completed
• Mild and Rapidly Improving Stroke Study — Completed
• Tinostamustine Conditioning and Autologous Stem Cell — Stopped early
• NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™ — Completed
• A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors — Completed
• LutrePulse Hypogonadotropic Hypogonadism — Completed
• A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) — Completed
• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer — Completed
• Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis — Completed
• Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV — Completed
• Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury — Completed
• Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence — Completed
• Permanent Versus Absorbable Colpopexy Trial — Completed
• Validation Study of ClassIntra® — Completed
• A Study of Tadalafil for Duchenne Muscular Dystrophy — Stopped early
• Miromatrix Biological Mesh for Hiatal Hernia Repair — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children — Completed
• A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases — Completed
• A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer — Completed
• Study of Oral Fampridine-SR in Multiple Sclerosis — Completed
• Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay — Completed
• Early Diagnosis of Pulmonary Nodules — Completed
• Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — NO_LONGER_AVAILABLE
• Progel Vascular Sealant — Completed
• Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma — NO_LONGER_AVAILABLE
• Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder — Completed
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI) — Completed
• Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. — Withdrawn before enrolling
• STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors — Completed